Projects per year
Organization profile
Organization profile
The Center for Drug Design (CDD) is a distinctive, cutting edge research facility in the Academic Health Center of the University of Minnesota. We are dedicated to: Providing a research environment for leading scientists, Sharing unique strategies within the scientific community, Developing novel drug therapies, Vigorously pursuing an academic research agenda, Transferring scientific knowledge, Designing and developing new medicines to benefit people worldwide, Supporting the interaction of many disciplines and areas of study, and Creating a focal point for research.
Fingerprint
Collaborations and top research areas from the last five years
Profiles
-
Monoaminergic neurotransmitter impairment from TBI as an early mechanism in neurodegenerative disease
THE HENRY M. JACKSON FOUNDATION, U.S. DEPARTMENT OF DEFENSE
4/10/23 → 4/9/27
Project: Research project
-
Cancer sensitizing effect of deazaflavin analogs is associated with increased intracellular drug accumulation
Belhadj, Z., Offei, S., Jacobson, B. A., Cambron, D., Kratzke, R. A., Wang, Z. & Xie, J., Feb 1 2024, In: European Journal of Pharmaceutical Sciences. 193, 106686.Research output: Contribution to journal › Article › peer-review
Open Access -
Current perspective on amyloid aggregation accelerating properties of the artificial butter flavoring, diacetyl
Vartak, A. P. & More, S. S., Oct 2024, In: Neural Regeneration Research. 19, 10, p. 2113-2114 2 p.Research output: Contribution to journal › Article › peer-review
Open Access -
5-((3-Amidobenzyl)oxy)nicotinamides as SIRT2 Inhibitors: A Study of Constrained Analogs
Ai, T., Wilson, D. & Chen, L., Nov 2023, In: Molecules. 28, 22, 7655.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations
Press/Media
-
Minnesota researchers look Alzheimer's in the eye: BTN LiveBIG
6/13/20
1 item of Media coverage
Press/Media: Research